Ramipril treatment suppresses islet fibrosis in Otsuka Long–Evans Tokushima fatty rats

Authors
Seung-Hyun KoHyuk-Sang KwonSung-Rae KimSung-Dae MoonYu-Bae AhnKi-Ho SongHyun-Sik SonBong-Yun ChaKwang-Woo LeeHo-Young SonSung-Koo KangChung-Gyu ParkIn-Kyu LeeKun-Ho Yoon
Department
Dept. of Internal Medicine (내과학)
Issue Date
2004
Citation
Biochemical and Biophysical Research Communications, Vol.316(1) : 114-122, 2004
ISSN
0006-291X
Abstract
We evaluated whether ramipril, one of long-acting ACEIs, has a direct effect on pancreas islets in animal model of type 2 diabetes. OLETF rats were treated with ramipril for 24 weeks. We assessed the body weight, glucose tolerance, and the amount of islet fibrosis. RT-PCR and Western blot analysis of transforming growth factor-β with its downstream signals were performed from the pancreas. Ramipril treatment remarkably reduced weight gain and the area under the curve of glucose. Islet fibrosis and the expression of TGF-β with its downstream signal molecules were significantly reduced in the pancreas of ramipril-treated group than in control and paired-feeding group. These beneficial effects of ramipril might be related to the downregulation of TGF-β and its downstream signals in OLETF rats. To our knowledge, this is the first report suggesting the potential effect of ramipril on the prevention of islet destruction by fibrosis in the animal model of type 2 diabetes mellitus. Keywords Ramipril; Otsuka Long–Evans Tokushima fatty rat; Islet fibrosis; Transforming growth factor-β; α-Smooth muscle actin
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/35171
Appears in Collections:
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
Keimyung Author(s)
이인규
Full Text
https://linkinghub.elsevier.com/retrieve/pii/S0006291X04002487
File in this Item
 사서에게 요청하기
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE